Merck (MRK GY) FY 2025 (EUR): EPS 8.34 (exp. 8.34), Net revenue 21.1bln (prev. 21.2bln Y/Y), guides 2026 revenue between 20.0-21.18 (exp. 21.2bln), proposes dividend of EUR 2.20/shr
Importance
Level 1
#GERMANY#EUROPE#MERCK & CO INC#MERCK KGAA#MRK.GY#IMPORTANT#EQUITIES#ASIAN SESSION#EU SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#DAX 40 INDEX#MRK